First patient receives controversial Biogen Alzheimer's drug
Go back to First patient receives controversial Biogen Alzheimer's drug| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 218.43 -3.72 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.15 | 52 Week High | $333.65 | |||
| Open | $220.15 | 52 Week Low | $223.02 | |||
| Day High | $223.09 | P/E | 27.97 | |||
| Day Low | $215.73 | EPS | $7.81 | |||
| Volume | 1,339,056 | |||||



